Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers: Guidance for Institutional Review Boards, Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 15, 2016
January 26, 2021
86634097-60db-4d53-bf74-1518a536d9df
Related Documents
Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Guidance DocumentDecember 22, 2023Center for Drug Evaluation and Research
A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry
Guidance DocumentApril 12, 2023Center for Drug Evaluation and Research
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry
Guidance DocumentJuly 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.